Related Experiment Videos
The UK Expert Patients Program: lessons learned and implications for cancer survivors' self-care support programs
1Centre for Research in Primary & Community Care, University of Hertfordshire, College Lane, Hatfield, AL10 9AB, UK. p.m.wilson@herts.ac.uk
Journal of Cancer Survivorship : Research and Practice
|July 24, 2008
Summary
The Expert Patients Program (EPP) and Chronic Disease Self-Management Program (CDSMP) improve self-efficacy in chronic disease patients. Lessons from the EPP can inform self-care programs for cancer survivors, though healthcare utilization effects were not significant.
Area of Science:
- Public Health
- Health Services Research
- Patient Self-Management
Background:
- Self-care is crucial for chronic disease management globally.
- The UK's Expert Patients Program (EPP) is a key self-care policy initiative.
- EPP is based on the Chronic Disease Self-Management Program (CDSMP).
Purpose of the Study:
- To analyze evaluations of EPP and CDSMP.
- To explore implications for developing self-management programs for cancer survivors.
Main Methods:
- Review of evaluations of CDSMP and EPP.
- Analysis of program strengths and contextual challenges.
- Qualitative assessment of peer support and learning.
Main Results:
- CDSMP and EPP improved participants' self-efficacy and health status.
- No significant reduction in healthcare utilization was observed for EPP.
- Qualitative data highlighted peer support as a key strength of EPP.
- Identified challenges included recruitment, clinician engagement, and inflexible materials.
Conclusions:
- Lay-led self-care programs like EPP positively impact self-efficacy.
- These programs may benefit cancer survivors.
- Lessons learned from EPP implementation are crucial for future initiatives.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...